Showing results (31-40 of 2,336) with videos related to
Sort By:
Pageof 234
Clinical Lung Cancer|October 3, 2015
Renin-Angiotensin System Inhibitors Might Help to Reduce the Development of Symptomatic Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung CancerStefano Bracci, Maurizio Valeriani, Linda Agolli, et al.Clinical Lung Cancer|October 26, 2013
Stereotactic body radiation therapy in octogenarians with stage I lung cancerAjay P Sandhu, Steven K M Lau, Douglas Rahn, et al.Clinical Lung Cancer|December 24, 2013
A randomized phase III study of single-agent amrubicin vs. carboplatin/etoposide in elderly patients with extensive-disease small-cell lung cancerIkuo Sekine, Hiroaki Okamoto, Takeshi Horai, et al.Clinical Lung Cancer|January 1, 2014
A tabulated summary of targeted and biologic therapies for non-small-cell lung cancerGeorge R Simon, Neeta SomaiahClinical Lung Cancer|June 5, 2012
Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases BoardSteven C Kao, Janette Vardy, Mark Chatfield, et al.Clinical Lung Cancer|June 5, 2012
Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokersYongjun Zhang, Shi Hua, Aiqin Zhang, et al.Clinical Lung Cancer|June 5, 2012
A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancerPeter M Ellis, Quincy S Chu, Natasha Leighl, et al.Clinical Lung Cancer|May 22, 2012
A phase Ib, dose-finding study of erlotinib in combination with a fixed dose of pertuzumab in patients with advanced non-small-cell lung cancerEnriqueta Felip, Malcolm Ranson, Susana Cedrés, et al.Clinical Lung Cancer|July 12, 2016
Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research GroupAthanasios Karampeazis, Lambros Vamvakas, Nikolaos Kentepozidis, et al.Clinical Lung Cancer|September 23, 2017
Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non-Small-cell Lung CancerEdward Kim, Rebecca Feldman, Ignacio I WistubaPageof 234